Nina Paonessa
Colon & Rectal Surgery · Brielle, NJNPI 1174503197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Lumenis BE Inc accounts for 76.4% of it on its own, with 4 other manufacturers making up the rest. 2024 is the largest year on record at $1,240, more than ten times the $26 reported in 2019. That places this record below the midpoint for colon & rectal surgery clinicians in NJ, where the typical reported total is $1,276.
Across 11 payments — averaging $145.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$1K
- THD America, Inc.$315
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$27
- Teleflex LLC$22
- Takeda Pharmaceuticals U.S.A., Inc.$13
What the payments were for
- Food & beverage$1,595100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $1,218 |
| THD America, Inc. | 6 | $315 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Teleflex LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- M22$1,218
How this compares
$1,595 in reported general payments places this provider in the 50th percentile of 86 colon & rectal surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 20 | $10,179 |
| CholestyramineCholestyramine (With Sugar) | 13 | $2,750 |
| Colestipol Hcl | 14 | $2,049 |
| Metronidazole | 17 | $176 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $115 |
| Ciprofloxacin Hcl | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Brielle
- Steven Lee-KongHackensack$55K
- Ashlee Godshalk RugglesPennington$44K
- John BerryPennington$36K
- Thomas LakeOakhurst$15K
- Glenn ParkerOakhurst$14K
- Daniel FeingoldNew Brunswick$14K
- Kulvir NandraGlen Ridge$12K
- Michele MalitHolmdel$11K
- Brendan ScullyNew Brunswick$11K
- Steven TizioTinton Falls$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.